Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Sodium-Glucose Transporter 2 Inhibitors”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT03202667
What this trial is testing

Effects of the SGLT2-inhibitor Empagliflozin on Patients With Chronic SIADH - the SANDx Study

Who this might be right for
SIAD - Syndrome of Inappropriate AntidiuresisHyponatremia
University Hospital, Basel, Switzerland 17
Not applicableEnded earlyNCT05341388
What this trial is testing

The Effect of SGLT2 Inhibitors on Cognitive Functions and BDNF Levels in Patients With Type 2 Diabetes

Who this might be right for
Type2 DiabetesCognitive Impairment
Goztepe Training and Research Hospital 25
Post-approval studies (Phase 4)Not Yet RecruitingNCT07547878
What this trial is testing

Rapid and Simultaneous Initiation of Four Guideline-Directed CKD Therapies (RAPID-CKD)

Who this might be right for
Chronic Kidney DiseaseType 2 Diabetes
Baylor Research Institute 64
Large-scale testing (Phase 3)Study completedNCT06221969
What this trial is testing

A Research Study to See How Much CagriSema Lowers Blood Sugar and Body Weight Compared to Tirzepatide in People With Type 2 Diabetes Treated With Metformin With or Without an SGLT2 Inhibitor

Who this might be right for
Type 2 Diabetes
Novo Nordisk A/S 1,024
Testing effectiveness (Phase 2)Looking for participantsNCT05469659
What this trial is testing

Effect of Tofogliflozin on UACR Compared to Metformin Hydrochloride in Diabetic Kidney Disease (TRUTH-DKD)

Who this might be right for
T2DM (Type 2 Diabetes Mellitus)MetforminSGLT2-Inhibitors
Shinshu University 120
Testing effectiveness (Phase 2)Study completedNCT06688123
What this trial is testing

Efficacy and Safety of SHR-3167 and Insulin Glargine in Type 2 Diabetes Subjects

Who this might be right for
Type 2 Diabetes
Jiangsu HengRui Medicine Co., Ltd. 275
Not applicableActive Not RecruitingNCT07188545
What this trial is testing

Using Secondary Data to Evaluate Sex-based Heterogeneity of GLP-1 Agonists and SGLT2 Inhibitors on Cardiovascular-Kidney-Metabolic Health (CKMH) Outcomes in Real-world Settings (DASH-CKMH)

Who this might be right for
Cardiovascular Kidney Metabolic Syndrome
Ohio State University 23,280,000
Testing effectiveness (Phase 2)Study completedNCT05570305
What this trial is testing

Zibotentan and Dapagliflozin in Patients With Type 2 Diabetes and Elevated Albuminuria

Who this might be right for
Chronic Kidney Diseases
University Medical Center Groningen 42
Not applicableUnknownNCT06128096
What this trial is testing

The Effect of SGLT-2 Inhibitors on Epicardial Adipose Tissue and Cardiac Function in T2DM Patients With CAD (EpiCAD)

Who this might be right for
Coronary Artery Disease
Clinical Research Centre, Malaysia 360
Very early researchStudy completedNCT04167761
What this trial is testing

Ertugliflozin: Cardioprotective Effects on Epicardial Fat

Who this might be right for
Cardiovascular DiseasesAtherosclerosisType 2 Diabetes+1 more
Stanford University 61
Testing effectiveness (Phase 2)Looking for participantsNCT07175051
What this trial is testing

Targeting the Pathophysiology of Sickle Cell-Related Kidney Disease Using the SGLT2 Inhibitors, Empagliflozin

Who this might be right for
Sickle Cell Anemia (HbSS, or HbSβ-thalassemia0)Albuminuria
University of Illinois at Chicago 20
Large-scale testing (Phase 3)Study completedNCT03087773
What this trial is testing

Impact of EMpagliflozin on Cardiac Function and Biomarkers of Heart Failure in Patients With Acute MYocardial Infarction

Who this might be right for
Acute Myocardial Infarction
Medical University of Graz 476
Not applicableUnknownNCT05408936
What this trial is testing

SGLT2 Inhibitors and Effects on Hematopoiesis, Inflammation and Metabolic Markers

Who this might be right for
Diabetes Mellitus, Type 2
University of Patras 80
Post-approval studies (Phase 4)Study completedNCT06383832
What this trial is testing

Effect of Dapagliflozin on Body Weight in Overweight Women Consuming Different Proportions of Carbohydrate Diet.

Who this might be right for
OverweightCarbohydrateSodium-glucose Transporter 2 Inhibitors
Sun Jia 36
Not applicableStudy completedNCT06453577
What this trial is testing

Pharmacokinetics of Bisoprolol and SGLT2i in Acutely Decompensated Heart Failure

Who this might be right for
Acute Decompensated Heart Failure
Universität des Saarlandes 33
Post-approval studies (Phase 4)Study completedNCT06268977
What this trial is testing

Adding SGLt2 Inhibitors to Patients With Type 2 Diabetes

Who this might be right for
Type 2 Diabetes
Assiut University 482
Early research (Phase 1)Active Not RecruitingNCT05662865
What this trial is testing

Low-CArbohydrate Diet and SGLT2-INhibitOr to Achieve Moderate Ketosis in Healthy Volunteers

Who this might be right for
Ketones, Metabolism
AdventHealth Translational Research Institute 9
Post-approval studies (Phase 4)Study completedNCT04219124
What this trial is testing

The Effect of a SGLT2 Inhibitor on Glucose Flux, Lipolysis and Exercise in Type 2 Diabetes

Who this might be right for
Type 2 Diabetes
University of Leicester 9
Post-approval studies (Phase 4)Study completedNCT04080518
What this trial is testing

Hepato-renal Regulation of Water Conservation in Heart Failure Patients With SGLT-2 Inhibitor Treatment

Who this might be right for
Diabetes MellitusHeart Failure
National Heart Centre Singapore 40
Large-scale testing (Phase 3)Looking for participantsNCT07214818
What this trial is testing

SGLT2 Inhibitors in Adult Primary Nephrotic Syndrome

Who this might be right for
Nephrotic Syndrome
Mansoura University 75
Next Page